Cargando…

The Utility of Phosphohistone H3 in Inter-Observer Variability of Mitotic Count in Meningioma, is There Any Benefit?

OBJECTIVE: One of the most reliable and decisive histologic parameters with negative prognostic impact is tumor proliferation capacity . Quantification of mitosis in H&E stained slides could be problematic and is limited by poor reproducibility and lack of objectivity. This study was designed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Saffar, Hana, Okhovat, Hoda, Arbabsoleymani, Saeed, Tavangar, Seyed Mohammad, Khoshnevisan, Alireza, Hajinasrollah, Ghazal, Hamidi Afra, Zahra, Saffar, Hiva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607091/
https://www.ncbi.nlm.nih.gov/pubmed/34319026
http://dx.doi.org/10.31557/APJCP.2021.22.7.2049
_version_ 1784602485363572736
author Saffar, Hana
Okhovat, Hoda
Arbabsoleymani, Saeed
Tavangar, Seyed Mohammad
Khoshnevisan, Alireza
Hajinasrollah, Ghazal
Hamidi Afra, Zahra
Saffar, Hiva
author_facet Saffar, Hana
Okhovat, Hoda
Arbabsoleymani, Saeed
Tavangar, Seyed Mohammad
Khoshnevisan, Alireza
Hajinasrollah, Ghazal
Hamidi Afra, Zahra
Saffar, Hiva
author_sort Saffar, Hana
collection PubMed
description OBJECTIVE: One of the most reliable and decisive histologic parameters with negative prognostic impact is tumor proliferation capacity . Quantification of mitosis in H&E stained slides could be problematic and is limited by poor reproducibility and lack of objectivity. This study was designed to evaluate inter-observer variability in mitotic count using Phosphohistone H3(PHH3). METHODS: Totally, 60 specimens with histologic diagnosis of meningioma were selected including 50 grade I, 7 grdae II and 3 grade III tumors. Mitotic figures were counted both in H&E stained sections and slides prepared by immunohistochemistry using Anti-Phosphohistone H3 Anti body by three observers with various level of expertise, independently. RESULTS: Mean mitotic count by PHH3 method was higher than H&E staining for all three observers. Observer 1 and 2 revealed good correlation in mitotic count using H&E method, while observer 3 showed disagreement with both of them. However, all of them had good correlation in mitotic count using PHH3 method (cc=0.956,0.947,0.909). CONCLUSION: Based on our findings, PHH3 revealed good agreement between pathologists with various level of expertise and has the capability for further contribution in meningioma grading classification and specially could be beneficial for less experienced pathologists.
format Online
Article
Text
id pubmed-8607091
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher West Asia Organization for Cancer Prevention
record_format MEDLINE/PubMed
spelling pubmed-86070912021-11-26 The Utility of Phosphohistone H3 in Inter-Observer Variability of Mitotic Count in Meningioma, is There Any Benefit? Saffar, Hana Okhovat, Hoda Arbabsoleymani, Saeed Tavangar, Seyed Mohammad Khoshnevisan, Alireza Hajinasrollah, Ghazal Hamidi Afra, Zahra Saffar, Hiva Asian Pac J Cancer Prev Research Article OBJECTIVE: One of the most reliable and decisive histologic parameters with negative prognostic impact is tumor proliferation capacity . Quantification of mitosis in H&E stained slides could be problematic and is limited by poor reproducibility and lack of objectivity. This study was designed to evaluate inter-observer variability in mitotic count using Phosphohistone H3(PHH3). METHODS: Totally, 60 specimens with histologic diagnosis of meningioma were selected including 50 grade I, 7 grdae II and 3 grade III tumors. Mitotic figures were counted both in H&E stained sections and slides prepared by immunohistochemistry using Anti-Phosphohistone H3 Anti body by three observers with various level of expertise, independently. RESULTS: Mean mitotic count by PHH3 method was higher than H&E staining for all three observers. Observer 1 and 2 revealed good correlation in mitotic count using H&E method, while observer 3 showed disagreement with both of them. However, all of them had good correlation in mitotic count using PHH3 method (cc=0.956,0.947,0.909). CONCLUSION: Based on our findings, PHH3 revealed good agreement between pathologists with various level of expertise and has the capability for further contribution in meningioma grading classification and specially could be beneficial for less experienced pathologists. West Asia Organization for Cancer Prevention 2021-07 /pmc/articles/PMC8607091/ /pubmed/34319026 http://dx.doi.org/10.31557/APJCP.2021.22.7.2049 Text en https://creativecommons.org/licenses/by/3.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/ (https://creativecommons.org/licenses/by/3.0/) ) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Saffar, Hana
Okhovat, Hoda
Arbabsoleymani, Saeed
Tavangar, Seyed Mohammad
Khoshnevisan, Alireza
Hajinasrollah, Ghazal
Hamidi Afra, Zahra
Saffar, Hiva
The Utility of Phosphohistone H3 in Inter-Observer Variability of Mitotic Count in Meningioma, is There Any Benefit?
title The Utility of Phosphohistone H3 in Inter-Observer Variability of Mitotic Count in Meningioma, is There Any Benefit?
title_full The Utility of Phosphohistone H3 in Inter-Observer Variability of Mitotic Count in Meningioma, is There Any Benefit?
title_fullStr The Utility of Phosphohistone H3 in Inter-Observer Variability of Mitotic Count in Meningioma, is There Any Benefit?
title_full_unstemmed The Utility of Phosphohistone H3 in Inter-Observer Variability of Mitotic Count in Meningioma, is There Any Benefit?
title_short The Utility of Phosphohistone H3 in Inter-Observer Variability of Mitotic Count in Meningioma, is There Any Benefit?
title_sort utility of phosphohistone h3 in inter-observer variability of mitotic count in meningioma, is there any benefit?
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607091/
https://www.ncbi.nlm.nih.gov/pubmed/34319026
http://dx.doi.org/10.31557/APJCP.2021.22.7.2049
work_keys_str_mv AT saffarhana theutilityofphosphohistoneh3ininterobservervariabilityofmitoticcountinmeningiomaisthereanybenefit
AT okhovathoda theutilityofphosphohistoneh3ininterobservervariabilityofmitoticcountinmeningiomaisthereanybenefit
AT arbabsoleymanisaeed theutilityofphosphohistoneh3ininterobservervariabilityofmitoticcountinmeningiomaisthereanybenefit
AT tavangarseyedmohammad theutilityofphosphohistoneh3ininterobservervariabilityofmitoticcountinmeningiomaisthereanybenefit
AT khoshnevisanalireza theutilityofphosphohistoneh3ininterobservervariabilityofmitoticcountinmeningiomaisthereanybenefit
AT hajinasrollahghazal theutilityofphosphohistoneh3ininterobservervariabilityofmitoticcountinmeningiomaisthereanybenefit
AT hamidiafrazahra theutilityofphosphohistoneh3ininterobservervariabilityofmitoticcountinmeningiomaisthereanybenefit
AT saffarhiva theutilityofphosphohistoneh3ininterobservervariabilityofmitoticcountinmeningiomaisthereanybenefit
AT saffarhana utilityofphosphohistoneh3ininterobservervariabilityofmitoticcountinmeningiomaisthereanybenefit
AT okhovathoda utilityofphosphohistoneh3ininterobservervariabilityofmitoticcountinmeningiomaisthereanybenefit
AT arbabsoleymanisaeed utilityofphosphohistoneh3ininterobservervariabilityofmitoticcountinmeningiomaisthereanybenefit
AT tavangarseyedmohammad utilityofphosphohistoneh3ininterobservervariabilityofmitoticcountinmeningiomaisthereanybenefit
AT khoshnevisanalireza utilityofphosphohistoneh3ininterobservervariabilityofmitoticcountinmeningiomaisthereanybenefit
AT hajinasrollahghazal utilityofphosphohistoneh3ininterobservervariabilityofmitoticcountinmeningiomaisthereanybenefit
AT hamidiafrazahra utilityofphosphohistoneh3ininterobservervariabilityofmitoticcountinmeningiomaisthereanybenefit
AT saffarhiva utilityofphosphohistoneh3ininterobservervariabilityofmitoticcountinmeningiomaisthereanybenefit